Kidney function and rate of bone loss at the hip and spine: the Canadian Multicentre Osteoporosis Study
- PMID: 20042259
- DOI: 10.1053/j.ajkd.2009.10.049
Kidney function and rate of bone loss at the hip and spine: the Canadian Multicentre Osteoporosis Study
Retraction in
-
Retraction Notice to "Kidney Function and Rate of Bone Loss at the Hip and Spine: The Canadian Multicentre Osteoporosis Study" [Am J Kidney Dis. 55(2):291-299].Am J Kidney Dis. 2016 Aug;68(2):333. doi: 10.1053/j.ajkd.2016.06.005. Epub 2016 Jul 21. Am J Kidney Dis. 2016. PMID: 27477359 No abstract available.
Abstract
Background: The relationship between kidney function and bone loss is unclear.
Study design: A prospective observational study.
Setting & participants: 191 men and 444 women aged > or = 50 years participating in a population-based observational study designed to determine risk factors for bone loss and fractures.
Predictors: The primary predictor of change in bone mineral density (BMD) was estimated creatinine clearance (using the Cockcroft-Gault formula) measured at baseline and stratified by quartiles. Our secondary predictor was estimated glomerular filtration rate using the Modification of Diet in Renal Disease Study equation, also stratified by quartiles.
Outcomes & measurements: Changes in BMD at the lumbar spine, total hip, and femoral neck during 5 years.
Results: Compared with participants in the first quartile of estimated creatinine clearance (>101.2 mL/min), those in remaining quartiles were older (quartile 1, 50.0 years; quartile 2 [101.2-83.4 mL/min], 54.7 years; quartile 3 [83.4-68.3 mL/min], 60.5 years; and quartile 4 [<68.3 mL/min], 68.3 years); weighed less; reported more sedentary hours; were less likely to report excellent, very good, or good self-reported health; consumed less caffeine; and had lower serum calcium and phosphate and higher serum parathyroid hormone levels. After adjusting for age, weight, sex, baseline BMD, and these differences, compared with those in the first quartile, those in the fourth quartile had decreases in BMD of 0.08 g/cm(2) (95% CI, 0.04-0.1) at the lumbar spine, 0.08 g/cm(2) (95% CI, 0.06-0.1) at the femoral neck, and 0.09 g/cm(2) (95% CI, 0.07-0.1) at the total hip. Bone loss did not increase with worsening kidney function (P for trend > 0.05). Results were not substantially different using estimated glomerular filtration rate.
Limitations: Observational study design and indirect measures of kidney function.
Conclusions: Men and women with impaired kidney function are at increased risk of bone loss, even with minimal reduction in kidney function.
Copyright 2010 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Measures of renal function, BMD, bone loss, and osteoporotic fracture in older adults: the Rancho Bernardo study.J Bone Miner Res. 2007 Feb;22(2):203-10. doi: 10.1359/jbmr.061014. J Bone Miner Res. 2007. PMID: 17059370 Free PMC article.
-
Lower Serum Creatinine Is Associated with Low Bone Mineral Density in Subjects without Overt Nephropathy.PLoS One. 2015 Jul 24;10(7):e0133062. doi: 10.1371/journal.pone.0133062. eCollection 2015. PLoS One. 2015. PMID: 26207750 Free PMC article.
-
Teriparatide in postmenopausal women with osteoporosis and mild or moderate renal impairment.Osteoporos Int. 2007 Jan;18(1):59-68. doi: 10.1007/s00198-006-0189-8. Epub 2006 Sep 30. Osteoporos Int. 2007. PMID: 17013567 Clinical Trial.
-
Renal function and rate of hip bone loss in older men: the Osteoporotic Fractures in Men Study.Osteoporos Int. 2008 Nov;19(11):1549-56. doi: 10.1007/s00198-008-0608-0. Epub 2008 Apr 5. Osteoporos Int. 2008. PMID: 18392664
-
Alendronate treatment in women with normal to severely impaired renal function: an analysis of the fracture intervention trial.J Bone Miner Res. 2007 Apr;22(4):503-8. doi: 10.1359/jbmr.070112. J Bone Miner Res. 2007. PMID: 17243862 Clinical Trial.
Cited by
-
Bisphosphonates to reduce bone fractures in stage 3B+ chronic kidney disease: a propensity score-matched cohort study.Health Technol Assess. 2021 Mar;25(17):1-106. doi: 10.3310/hta25170. Health Technol Assess. 2021. PMID: 33739919 Free PMC article.
-
Correlation of Fgf23 and Balp with Bone Mineral Density in Hemodialysis Patients.J Med Biochem. 2019 Jul 30;38(4):418-426. doi: 10.2478/jomb-2019-0002. eCollection 2019 Oct. J Med Biochem. 2019. PMID: 31496905 Free PMC article.
-
Bone health in type 1 diabetes: focus on evaluation and treatment in clinical practice.J Endocrinol Invest. 2015 Sep;38(9):941-50. doi: 10.1007/s40618-015-0284-9. Epub 2015 Apr 12. J Endocrinol Invest. 2015. PMID: 25863666 Review.
-
Low bone mineral density and its predictors in type 1 diabetic patients evaluated by the classic statistics and artificial neural network analysis.Diabetes Care. 2011 Oct;34(10):2186-91. doi: 10.2337/dc11-0764. Epub 2011 Aug 18. Diabetes Care. 2011. PMID: 21852680 Free PMC article.
-
Renal Function and Bone Loss in a Cohort of Afro-Caribbean Men.J Bone Miner Res. 2015 Dec;30(12):2215-20. doi: 10.1002/jbmr.2562. Epub 2015 Jun 16. J Bone Miner Res. 2015. PMID: 26011289 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources